Talapro-2: A Two-Part, Placebo-Controlled Phase Iii Study Of Talazoparib (Tala) With Enzalutamide (Enza) In Metastatic Castration-Resistant Prostate Cancer (Mcrpc).
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2019)